Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-10-12
1977-09-20
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
42424857, 424267, 424274, 424329, A61K 31135, A61K 31535, A61K 31445, A61K 3114, A61K 3140
Patent
active
040498271
ABSTRACT:
4,4-Diphenyl-2-hydroxybutylamines are prepared by condensing amines with 1,2-epoxy-4,4-diphenylbutanes. The new compounds exist in the free base form, as acid addition salts and quaternary ammonium salts, and exhibit antiarrhythmic activity.
REFERENCES:
patent: 2891890 (1959-06-01), Adamson
patent: 3395146 (1968-07-01), Satzinger
patent: 3412091 (1968-11-01), Moffett
patent: 3433836 (1969-03-01), Petracek
patent: 3439035 (1969-04-01), Grisar et al.
patent: 3987201 (1976-10-01), Molloy
Blank et al., J. Med. Chem. pp. 271-276 (1969).
Chemical Abstracts: Benoit et al., vol. 46, p. 476 (1952); Morikawa, vol. 54, pp. 19588-19589 (1960); and Seidlova, et al., vol. 62, pp. 11709-11710 (1965).
Ashbrook Charles W.
Eli Lilly and Company
Moyer Donald B.
Smith Everet F.
LandOfFree
Method of treating arrhythmia with diarylbutanolamines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating arrhythmia with diarylbutanolamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating arrhythmia with diarylbutanolamines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-671841